NeuroSense Therapeutics Investor Relations Material
Latest events
Q4 2024
7 Apr, 2025
Q3 2024
18 Dec, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from NeuroSense Therapeutics Ltd
Access all reports
NeuroSense Therapeutics Ltd is a biotechnology company focused on developing treatments for neurodegenerative diseases. The company specializes in multi-target drug therapies designed to address conditions such as amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and Alzheimer’s disease. The company is headquartered in Herzliya, Israel, and its shares are listed on the NASDAQ.
)
)
)